CSIMarket Company Name, Ticker, Customers, else..
 
Harpoon Therapeutics Inc   (NASDAQ: HARP)
Other Ticker:  
 
 

Harpoon Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



HARP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -67.33 % 5.39 % -0.27 % -0.67 %
Q / Q Revenue Growth (Q3 MRQ) -78 % 0.08 % 0.4 % -1.14 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 291.34 % 6.99 % - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -21.61 % 1.25 % - 0.04 %
Revenue 5 Year Average Growth - 7.89 % 11.06 % 11.04 %


HARP's Growth Comparisons in III. Quarter 2023




As Harpoon Therapeutics Inc 's sales faded by -67.33% year on year in the third quarter 2023, the Medical Equipment & Supplies industry grew by 5.39%, Harpoon Therapeutics Inc 's third quarter 2023 performance was trailing the Medical Equipment & Supplies industry in the third quarter 2023, and underperformed the -0.27% Revenue decrease in the Healthcare sector. Although both Medical Equipment & Supplies industry and Healthcare sector posted higher gains than -0.67% overall market increase, Harpoon Therapeutics Inc was trailing overall market in the third quarter.

Top-line fell by -78% from the second quarter results. Comparing the annual growth, sales of % on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2023 financial results, average yearly sales growth is 11.04%. Harpoon Therapeutics Inc grew less than the market.


Growth Rates of HARP's Income in the third quarter 2023


HARP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - -41.03 % -41.64 % 0.53 %
Seq. Operating Income Change (Q3 MRQ) - - 37.5 % 7.86 %
Y / Y Operating Income Growth (Q3 TTM) - -63.25 % -25.98 % -9.48 %
Seq. Operating Income Growth (Q3 TTM) - -20.9 % -12.47 % -0.31 %
Operating Income 5 Year Avg. Change - -2.55 % 10.12 % 10.67 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - -44.38 % -79.11 % 1.33 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - - 437.94 % 11.41 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -33.2 % -76.46 % -57 % -9.41 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 47.3 % -19.34 % -32.32 % 0.17 %
Income from Cont. Ops. 5 Year Avg. Change - -1.53 % 23.12 % 2.83 %

HARP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 53.95 % 6.18 % 6.99 %
Q / Q Net Income Growth (Q3 MRQ) - - 2837.28 % 15.58 %
Y / Y Net Income Change (Q3 TTM) -33.2 % -59.62 % -32.87 % -7.15 %
Seq. Net Income Change (Q3 TTM) 47.3 % 35.35 % 3.17 % 1.71 %
Net Income 5 Year Avg. Growth - -1.72 % 23.14 % 3.13 %

HARP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - -48.91 % -79.11 % 1.33 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - - 437.94 % 11.41 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -34.73 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 45.93 % - - 117.26 %
EPS from Cont. Ops. 5 Year Avg. Growth - -17.37 % 23.12 % 2.83 %



HARP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 41.41 % 6.18 % 2.83 %
Q / Q EPS Net Growth (Q3 MRQ) - - 2837.28 % 15.58 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 60266.88 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 45.93 % - - 115.79 %
EPS Net 5 Year Avg. Change - -1.72 % 23.14 % 3.13 %



Harpoon Therapeutics Inc reported bottom-line of $ -0.46 in the third quarter, compare to $ -3.50 in the same quarter a year ago. Medical Equipment & Supplies industry grew by 41.41%, while Healthcare sector increased by 6.18%, and overall market improved by 6.99%.

Bottom-line fell by -78% from the second quarter results. Comparing the annual growth, income per share of % on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2023 earnings, average yearly income per share growth is 3.13%. Harpoon Therapeutics Inc grew less than the market.

HARP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 29.26 % 4.92 % 25.44 %
Seq. Free Cash Flow Change (Q3 MRQ) - 20.82 % 51.62 % 29.02 %
Y / Y Free Cash Flow Change (Q3 TTM) - 15.91 % -9.21 % -3.19 %
Seq. Free Cash Flow Change (Q3 TTM) - 6.46 % 2.26 % 11.89 %
Free Cash Flow 5 Year Avg. Change - -4.47 % 18.54 % 23.33 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 224.29 % 7.7 % -
Seq. Net Cash Flow Change (Q3 MRQ) - 340.42 % - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - 678.64 % 15.06 % -
Net Cash Flow 5 Year Avg. Change - - -1.29 % 48.94 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -86 % 12.7 % 3.34 % 69.59 %
Seq. Capital Expenditures Change (Q3 MRQ) - 15.99 % 5.46 % 16.4 %
Y / Y Capital Expenditures Change (Q3 TTM) 230.56 % 9.04 % 5.4 % -8.48 %
Seq. Capital Expenditures Change (Q3 TTM) -61.03 % 4.68 % 0.76 % 18.81 %
Capital Expenditures 5 Year Avg. Change - 9.73 % 9.25 % 8.66 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com